JPH02250832A - Immunological enhancing agent for fishes and feed for fish-farming - Google Patents

Immunological enhancing agent for fishes and feed for fish-farming

Info

Publication number
JPH02250832A
JPH02250832A JP1073152A JP7315289A JPH02250832A JP H02250832 A JPH02250832 A JP H02250832A JP 1073152 A JP1073152 A JP 1073152A JP 7315289 A JP7315289 A JP 7315289A JP H02250832 A JPH02250832 A JP H02250832A
Authority
JP
Japan
Prior art keywords
fish
glycyrrhizin
feed
fishes
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1073152A
Other languages
Japanese (ja)
Other versions
JP2840851B2 (en
Inventor
Tomochika Edahiro
枝広 知新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IKEDA TOUKA KOGYO KK
Original Assignee
IKEDA TOUKA KOGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IKEDA TOUKA KOGYO KK filed Critical IKEDA TOUKA KOGYO KK
Priority to JP1073152A priority Critical patent/JP2840851B2/en
Publication of JPH02250832A publication Critical patent/JPH02250832A/en
Application granted granted Critical
Publication of JP2840851B2 publication Critical patent/JP2840851B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

PURPOSE:To obtain immunological enhancing agent toughening liver function of fishes and enhancing immunological competence containing glycyrrhizin as active ingredient. CONSTITUTION:The aimed immunological enhancing agent for fishes contains glycyrrhizin expressed by the formula as triterpene-based glucosides contained in root of Glycyrrhiza glabra L. as active ingredient. Administration is performed by mixing in feed and dose of the agent is >=5mg, preferably >=10mg per 1kg body weight of the object fishes. Said immunological enhancing agent is utilized to fish-farming in taking effect of excellent breeding result without affected by poor feed having high POV and hardly attacked with disease even in farming of high density.

Description

【発明の詳細な説明】[Detailed description of the invention] 【発明の目的】[Purpose of the invention]

[B業上の利用分野] 本発明は、魚類の肝機能を強化してその免疫力を高める
ための剤及び本則を含む養魚用餌料に関する。 [従来の技術] (1)背景 今日、各地の河川、湖沼、海湾などの内水面においては
、コイ、ニジマス、ウナギ、アユ、ボラ、ブリ、クロダ
イ、クルマエビ、マダイ、イカ、タコ、アワビ、カキ、
ホタテガイなどの養殖が盛んに行われており、3万km
にも及ぶ長大な海岸線を持つ我が国では、遠洋漁業にお
ける制約とも相まって、養殖乃至栽培漁業が益々重要性
を加えつつある。 (2従来技術の問題点 しかし、狭い水圏内に多数の魚介を飼養するこれら集約
漁業では、食べ刺し餌料や排泄物の腐敗などのため、生
活環境が自然状態に比べて劣悪な状態となるのが常であ
り、このため伝染性の病気が蔓延しやすい、そこで、餌
料中に抗生物質などの薬剤を添加することが普通に行わ
れているが、薬剤の投与は耐性菌の出現を促進するのみ
でなく、当該薬剤が魚介類の体内に蓄積され、結局最終
捕食者であるヒトが摂取することになるから、公衆衛生
的にも好ましくない(現に、抗生物質の残存量は厳しく
規制されている。)。 従って、若し可能ならば、魚介類自体の免疫力を高める
ことによって疾病に罹患しにくくすることにより、薬剤
の飼養を不必要とすることが望まれる。 [発明が解決しようとする課題] 本発明は、上の課題に応え、魚類の生体防御機能を高め
るための非抗生物質系稟剤及び当該薬剤を含有する餌料
を開発することによって、上記問題を解決するための手
段を提供するのを目的とする。
[Field of Industrial Application B] The present invention relates to a fish feed containing an agent and principles for strengthening the liver function of fish and increasing their immunity. [Prior art] (1) Background Today, carp, rainbow trout, eel, sweetfish, mullet, yellowtail, black sea bream, prawn, red sea bream, squid, octopus, abalone, and oysters are found in the inland waters of rivers, lakes, seas, and bays. ,
Cultivation of scallops and other species is actively carried out, and the area is 30,000 km long.
In Japan, which has a long coastline extending over 1,000 yen, aquaculture and cultivated fishing are becoming increasingly important due to restrictions on deep-sea fishing. (2) Problems with the conventional technology However, in these intensive fisheries where large numbers of fish and shellfish are kept in a small aquatic area, the living environment becomes worse than the natural state due to rotting bait and excrement. Therefore, it is common practice to add drugs such as antibiotics to the feed, but the administration of drugs promotes the emergence of resistant bacteria. Not only that, but the drugs accumulate in the bodies of fish and shellfish, and end up being ingested by humans, who are the ultimate predators, which is unfavorable from a public health standpoint (in fact, the amount of antibiotics remaining is strictly regulated). Therefore, if possible, it is desirable to make the feeding of drugs unnecessary by increasing the immunity of fish and shellfish themselves, thereby making them less susceptible to diseases. In response to the above-mentioned problems, the present invention provides means for solving the above-mentioned problems by developing a non-antibiotic drug for increasing the biological defense function of fish and a feed containing the drug. The purpose is to provide.

【発明の構成】[Structure of the invention]

[課題を解決するための手段〕 (1)概念 本発明者は、上記課題を解決するため鋭意検討を加えた
過程で、グリチルリチンの持つ哺乳動物に対する肝機能
及び免疫増強作用に着目し、魚類への薬理作用を観察し
たところ、下等な魚類においても哺乳動物の場合と類似
の作用が観察されたのみでなく、実際に連鎖球菌に対す
る免疫試験においても、有意の差異が認められた0本発
明は、この知見を基礎とするものである。 (21概要 本発明の要旨は、グリチルリチンを魚類の免疫増強剤と
して利用すること及びそのための簡便な手段として、グ
リチルリチンを養魚用の餌料中に含有させる点に存する
。 以下、発明を構成する諸要素等につき項分けして説明す
る。 (3)  グリチルリチン グリチルリチン(glycyrrhizin)  (下
式)は、南ヨーロッパから中央アジアにかけて自生する
マメ科植物カンゾウ(甘草) CGIycyrrhjz
a 1labraL、 、 G、11abra L、v
ar、11anduljfera Re1.et He
rd。 G、echinata L、、 G、 uralens
fs fi#sch et DC,等)の根に含まれる
トリテルペン系配糖体であって、そのアグリコンはグル
クロン酸ダイマーである。 G4+  グリチルリチンの魚類に対する作用(a)測
定項目 (イ)肝機能及び免疫増強機能:グリチルリチン投与開
始から3週間後に、各群から5尾づつ取り上げ、増重率
、ヘマトクリット値(赤血球容積率)、血清蛋白量、血
清アルブミン量、GOT (グルタミン酸−オキサロ酢
酸トランスアミナーゼ)値、GPT(グルタミン酸−ビ
ルピン酸トランスアミナーゼ)値、補体価、リゾチーム
活性、副腎マクロファージ貧食活性及びTNP−BSA
に対する凝集抗体価を測定した。 (T?)感染防御能:グリチルリチン投与開始から4週
間後に、連鎖球菌S−2433株の生菌で攻撃し、感染
防御機能の変化を観察した。 (b)実験方法 (イ)供試魚:高知県土佐市宇佐町の養殖業者より購入
した平均体重15.8gのブリ稚魚を用いた。 (υ)飼育方法:供試魚を帆8LのFRP製水槽に収容
し、エアレーションを行いながら飼育した。 (八)供試グリチルリチン:純度98%以上の高純度品
。 に)グリチルリチンの投与法:魚体重の12%量のイカ
ナゴミンチにグリチルリチンを、魚体重IKg当たり夫
々0(対照) 、2.5.5.0゜25.0及び50.
0II1gを展着剤((スタッシュ)大日本製薬■製)
と共に、−日一回、35日日間(5週間)投与した。 (ホ)免疫方法:グリチルリチン投与前に、TNP化牛
血清アルブミン(TNP−BSA)を供試魚の腹腔内に
接種した。対照区には整理食塩水を同様に接種した。 (へ)血液及び血漿の採取:第二回目の抗原接種から3
週間口に、各区10尾の魚を取り上げ、ヘパリン処理し
たシリンジを用いて心臓穿刺法により血液を採取した。 この血液を一夜4℃で保存後、遠心分離して血漿を採取
した。 (ト)血漿成分の測定:ヘマトクリット値の測定は常法
により行った。血清蛋白量は、ビユレット法により測定
した。血清中のGOT及びGPT値の測定は、夫々<G
OT UVテストワコー)及び<GPT UVテストワ
コー)(共に和光純薬■製)を用いて実施した。 (チ)血清補体価の測定:ウサギ赤血球を用い、Sa 
fat iら(1982)の方法により測定した。 (す)副腎細胞の貧食活性の測定:採血した供試魚から
直ちに副腎を取り出し、0.15%の食塩を含むL −
Is (Flow Laboratory)培地中で鋏
を用いて細切した後、白金メツシュで濾過して1×10
7細胞/−濃度の白血球浮遊液を作成した。賞食用粒子
には、各抗原を感作したラテックス(0,81μi、D
ifco)とFXCを用いた。感作ラテツクスの作製は
、高木・補出(19g2 >の方法により行った。貧食
は、細胞浮遊液0.5−と自己血清0.4m、  lX
l0’細胞/−に調整した貧食粒子0.1−を混合し、
25℃で3時間反応させた。 反応後、混合液100μgを取り出し、400×gの角
速度で5分間遠心して得られた沈渣を10−のウシ胎児
血清に懸濁してスメアを作製した。このスメアを乾燥後
、10%ホルマリン加エタノールで固定し、ペルオキシ
ダーゼ染色及びギムザ染色を行った後、検鏡し、100
個の貧食細胞に取り込まれた粒子数を算出した。 (ヌ)凝集抗体価の測定: THP−BS^を感作させ
たヒツジ赤血球(SRBC)を抗原として、マイクロタ
イター法により測定した。抗原の感作は、グルタルアル
デヒド処理5R8Cを用い、常法に従って行った。 (ル)実験的感染試験:グリチルリチン投与4週間後に
、供試魚を連鎖球菌に対する感染試験を行った。 先ず、BH1平板にて30℃、24時間培養した5tr
eptococcus sp、2433株の生菌体を滅
菌リン酸塩緩衝液に5.2 X 10’ CFU/−と
なるように懸濁し、この懸濁液各0.1−を、各区10
尾の供試魚の腹腔内に接種しな。 この実験的感染10日間飼育を続け、生残率の変化を調
べた。なお、各斃死魚は、夫々の腎臓から菌分離を行い
、抗5treptococcus血清を用いて連鎖球菌
症による斃死であることを確認した。 (c)実験結果 (イ)体重変化:グリチルリチン投与量と非投与区の体
重変化は添付第1図に示される。 図示の如く、グリチルリチン投与量が増加する程、実験
開始時−実験終了時曲線間の開きが大きくなる傾向が窺
われ、グリチルリチンの投与が稚魚の体重増加に有効で
あることが知られる。この原因は不明であるが、略々下
記のいづれかと考えてよいであろう。 ■ 餌の質をグリチルリチンが改善した。 ■ 免疫増強作用(補体価の上昇)との共同作用による
体質改善。 ■ グリチルリチンによるの解毒作用の効果。 ■ グリチルリチンによる肝機能向上の効果。 (ロ)血液性状の変化:グリチルリチンの投与によるヘ
マトクリット値及び血清蛋白量の変化は第2図に示され
る。 図示の通り、ヘマトクリット値及び血清蛋白量は、いづ
れもグリチルリチンの投与によって増加しており、投与
が血液の性状を良化していることが判る。因に、イワシ
ミンチのような酸化油脂含量の高い餌料を与えた場合、
ヘマトクリット値が低下することが知られているが、グ
リチルリチンを投与するとこの欠点が改善又は解消され
る。 (約肝機能の向上:グリチルリチンの投与が血清中のG
OT及びGPTの値に及ぼす影響は第3図に示される。 図示のように、グリチルリチンの投与によって、かつ投
与量に比例してGOT及びGPTの値が低下しており、
グリチルリチンによる肝機能向上の事実を窺うことがで
きる。 −iにハマチ養殖用の餌料は酸化油脂及び細菌の量が多
いため質が悪く、被養魚の肝機能を低下させ易い、この
ため連鎖球菌症などに感染する場合が多いが、グリチル
リチンは、肝機能強化を通じてこの問題を克服できる可
能性を示す、なお、本実験時の餌料は、前記の如くイカ
ナゴミンチが主体であるが、実際に利用されるイワシミ
ンチでは、より大きな差異が現れるであろう。 (ニ)免疫増強作用:第4図は、グリチルリチンの投与
が免疫力に関連する指標である補体価、リゾチーム活性
、貧食率及び凝集抗体価に及ぼす影響を示す。特に、グ
リチルリチン多量投与群におけるマクロファージ貧食率
の上昇は著しい、これらの結果から、グリチルリチンは
、既に)−11V(エイズウィルスなど)に対して認め
られているのと同様、魚類の病原菌に対しても免疫力を
強化する作用を奏する事実が推測される。このため、被
投与魚体の病原細菌やウィルスに対する抵抗力が増大し
、魚体を良好な健康状態に保つ効果を奏すべきことが期
待される。 〈ホ)連鎖球菌症に対する感染防御効果:第5図は、グ
リチルリチンの投与開始から4週間後に、連鎖球菌S−
2433株のL Om。量を接種したときのグリチルリ
チン投与量と生存率との関係を示す、このグラフから、
グリチルリチンは抗生物貫程劇的な作用を呈しないもの
の、投与量50mg/にg以上のレベルでは、生存率増
加のため原著な効果を奏することが明瞭である。 因に、実際の養魚場では、たとえ病気が発生してもL 
D m。程のレベルとは側底ならないので、この程度の
緩和な効果であっても実用的に充分である。 (51投与量及び餌料組成 本発明に係る魚類の肝機能剤及び強化及び養魚用餌料は
、対象魚類に対し、体重IKg当たり5mg以上、好ま
しくは1011g以上投与される。所望によりナトリウ
ム塩若しくはカリウム塩のような易溶性の塩又はカルシ
ウム塩若しくはアルミニウム塩のような難溶性の塩の形
で適用されてもよい。 相手が魚類である関係で、投与は餌料中に混ぜて行うの
が普通である。餌料としては、魚類の種類に応じ、魚粉
、サナギ粉、生魚肉のミンチ、穀粉、麩などが利用され
るが、いずれにしても、公知の粘結剤、例えばα化澱粉
、コムギブルチン、カゼインナトリウム、アルギン酸ナ
トリウム、ポリアクリル酸ナトリウム、カルボキシメチ
ルセルロースナトリウム、各種植物ガム、ダイズホエイ
等を用いて水中で容易には崩壊しない程度の粘結性を与
えておく必要がある。 [作用] 発明者の研究により、グリチルリチンは、魚類に対して
も肝機能向上、解毒、免疫増強等の作用を有することが
発見された。従って、これを魚類の養殖に利用すれば、
POVの高い劣悪な餌料にも悪影響を受けず、かつ高密
度の養殖でも疾病に冒され難い良好な飼育成績を奏する
。しかもグリチルリチンは天然物であって、抗生物質の
ように自然界の微生物バランスを崩したり又は魚体中に
蓄積したりすることがないから、安全な餌料添加物とし
て好適に利用されることが出来る。 [実施例] 以下、実施例により発明実施の態様を説明するが、例示
は単に説明用のもので、発明思想の制限又は限定を意味
するものではない。 生イワシ1kgに、α化澱粉50g、グリチルリチン2
0mg及びビタミンE(酸化防止剤> 10mgをミン
チでにかけて播潰物をラドン状に押し出し、熱風で軽く
乾燥させてブリ稚魚用生餌料約1kgを得た。 【発明の効果] 以上説明しかつ実証した通り、本発明は、魚類の生体防
御機能を高めるための非抗生物質薬剤及び当該薬剤を含
有する餌料を開発することによって、上記問題を解決す
るための手段を提供しえたことにより、栽培漁業の発展
に寄与しうる。 (以下余白)
[Means for Solving the Problems] (1) Concept In the process of conducting intensive studies to solve the above problems, the present inventor focused on the liver function and immune-enhancing effects of glycyrrhizin on mammals, and applied it to fish. When we observed the pharmacological effects of the present invention, not only were effects similar to those observed in mammals observed in lower fish species, but also significant differences were observed in an immunity test against streptococci. is based on this knowledge. (21 Overview The gist of the present invention is to utilize glycyrrhizin as an immune enhancer for fish, and to include glycyrrhizin in feed for fish farming as a simple means for that purpose. Below, various elements constituting the invention will be described. (3) Glycyrrhizin Glycyrrhizin (formula below) is a legume that grows wild from southern Europe to central Asia.
a 1labra L, , G, 11abra L, v
ar, 11anduljfera Re1. et He
rd. G, echinata L,, G, uralens
It is a triterpene-based glycoside contained in the roots of fs fi#sch et DC, etc.), and its aglycone is a glucuronic acid dimer. G4+ Effect of glycyrrhizin on fish (a) Measurement items (a) Liver function and immune enhancement function: Three weeks after the start of glycyrrhizin administration, 5 fish were taken from each group and weight gain rate, hematocrit value (red blood cell volume percentage), serum Protein content, serum albumin content, GOT (glutamate-oxaloacetate transaminase) value, GPT (glutamate-virupate transaminase) value, complement value, lysozyme activity, adrenal macrophage phagocytic activity, and TNP-BSA
The agglutinated antibody titer was measured. (T?) Infection protection ability: Four weeks after the start of glycyrrhizin administration, the cells were challenged with live Streptococcus S-2433 strain and changes in infection protection ability were observed. (b) Experimental method (a) Test fish: Young yellowtail fish with an average weight of 15.8 g purchased from a fish farmer in Usa-cho, Tosa City, Kochi Prefecture were used. (υ) Rearing method: Test fish were housed in an FRP aquarium with an 8L sail and reared while being aerated. (8) Test glycyrrhizin: High purity product with purity of 98% or more. 2) Glycyrrhizin administration method: Glycyrrhizin was added to minced squid in an amount of 12% of the fish body weight at doses of 0 (control), 2.5, 5.0, 25.0 and 50.
0II1g as a spreading agent ((Stash) manufactured by Dainippon Pharmaceutical ■)
The drug was also administered once on -day for 35 days (5 weeks). (e) Immunization method: Before administration of glycyrrhizin, TNP-modified bovine serum albumin (TNP-BSA) was intraperitoneally inoculated into the test fish. Control plots were similarly inoculated with saline. (f) Collection of blood and plasma: 3 from the second antigen vaccination
Every week, 10 fish from each group were taken, and blood was collected by cardiac puncture using a heparin-treated syringe. This blood was stored overnight at 4°C and then centrifuged to collect plasma. (g) Measurement of plasma components: Hematocrit values were measured by a conventional method. Serum protein level was measured by the Biulet method. Measurement of GOT and GPT values in serum was performed at <G
The test was carried out using OT UV Test Wako) and <GPT UV Test Wako) (both manufactured by Wako Pure Chemical Industries, Ltd.). (H) Measurement of serum complement value: Using rabbit red blood cells, Sa
It was measured by the method of Fati et al. (1982). (S) Measurement of hypophagic activity of adrenal cells: Immediately remove the adrenal glands from the blood sampled fish, and remove
After cutting into small pieces using scissors in Is (Flow Laboratory) medium, filtering through a platinum mesh to 1×10
A leukocyte suspension with a concentration of 7 cells/- was prepared. The prize edible particles were latex sensitized with each antigen (0.81μi, D
ifco) and FXC were used. The sensitized latex was prepared by the method of Takagi and Hideshi (19g2).
Mix 0.1 − of phagocytic particles adjusted to 10′ cells/−,
The reaction was carried out at 25°C for 3 hours. After the reaction, 100 μg of the mixture was taken out and centrifuged at an angular velocity of 400×g for 5 minutes, and the resulting precipitate was suspended in 10-fetal bovine serum to prepare a smear. After drying, this smear was fixed with 10% formalin and ethanol, peroxidase staining and Giemsa staining, and microscopic examination.
The number of particles taken up by each phagocyte was calculated. (J) Measurement of agglutination antibody titer: Measurement was carried out by a microtiter method using sheep red blood cells (SRBC) sensitized with THP-BS^ as an antigen. Antigen sensitization was performed using glutaraldehyde-treated 5R8C according to a conventional method. (l) Experimental infection test: Four weeks after administration of glycyrrhizin, the test fish were tested for infection with streptococci. First, 5tr was cultured on a BH1 plate at 30°C for 24 hours.
Eptococcus sp., strain 2433, was suspended in sterile phosphate buffer at a concentration of 5.2 x 10' CFU/-, and 0.1- of this suspension was added to 10 cells in each section.
Inoculate the tail of the test fish intraperitoneally. This experimental infection was continued for 10 days and changes in survival rate were examined. In addition, bacteria were isolated from each kidney of each dead fish, and using anti-5 treptococcus serum, it was confirmed that the fish had died due to streptococcus disease. (c) Experimental results (a) Body weight change: The weight change in the glycyrrhizin administration group and the non-administration group are shown in the attached Figure 1. As shown in the figure, it can be seen that as the amount of glycyrrhizin administered increases, the difference between the curves at the start of the experiment and at the end of the experiment tends to increase, indicating that administration of glycyrrhizin is effective in increasing the weight of young fish. Although the cause of this is unknown, it may be considered to be one of the following. ■ Glycyrrhizin improved feed quality. ■ Improves constitution due to synergistic effect with immune enhancing effect (increase in complement value). ■ Detoxifying effect of glycyrrhizin. ■ Effect of glycyrrhizin on improving liver function. (b) Changes in blood properties: Changes in hematocrit value and serum protein level due to administration of glycyrrhizin are shown in FIG. As shown in the figure, the hematocrit value and the serum protein level both increased with the administration of glycyrrhizin, indicating that the administration improved the properties of the blood. Incidentally, if you feed feed with a high content of oxidized fats and oils, such as minced sardines,
Although it is known that the hematocrit value decreases, administration of glycyrrhizin improves or eliminates this drawback. (Improvement of liver function: Glycyrrhizin administration increases serum G
The effect on the values of OT and GPT is shown in FIG. As shown in the figure, GOT and GPT values decreased by administration of glycyrrhizin and in proportion to the dose.
The fact that glycyrrhizin improves liver function can be seen. -i. Feed for cultivating yellowtail is of poor quality because it contains a large amount of oxidized oil and bacteria, and tends to reduce the liver function of the fish, which often leads to streptococcal infections. This shows the possibility of overcoming this problem through functional enhancement.The food used in this experiment was mainly squid minced sand eel, as mentioned above, but the sardine minced meat that is actually used will probably make a bigger difference. (d) Immune-enhancing effect: Figure 4 shows the effects of glycyrrhizin administration on complement value, lysozyme activity, phagocytosis rate, and agglutination antibody titer, which are indicators related to immunity. In particular, the increase in macrophage phagocytosis rate in the glycyrrhizin-dosing group was remarkable.From these results, glycyrrhizin is effective against fish pathogens, similar to what has already been shown against -11V (AIDS virus, etc.). It is also speculated that it has the effect of strengthening immunity. Therefore, it is expected that the resistance of the treated fish to pathogenic bacteria and viruses will increase, and that it will have the effect of keeping the fish in good health. (e) Infection-preventive effect against streptococcal disease: Figure 5 shows that Streptococcus S-
2433 shares of L Om. From this graph showing the relationship between glycyrrhizin dosage and survival rate when
Although glycyrrhizin does not exhibit a dramatic effect on antibiotics, it is clear that at doses of 50 mg/g or higher, it has a significant effect on increasing the survival rate. Incidentally, in actual fish farms, even if a disease occurs, L
Dm. Since this level is not considered to be basolateral, even this mild effect is sufficient for practical purposes. (51 Dosage and Feed Composition The fish liver function agent and fortification and fish culture feed according to the present invention are administered to target fish in an amount of 5 mg or more, preferably 1011 g or more per IKg of body weight. If desired, sodium salt or potassium salt is used. It may be applied in the form of easily soluble salts such as , or sparingly soluble salts such as calcium salts or aluminum salts.Since the target is fish, it is usually administered by mixing it into the feed. As feed, fish meal, pupa meal, minced raw fish meat, grain flour, wheat gluten, etc. are used depending on the type of fish, but in any case, known binders such as pregelatinized starch, wheat glutin, and casein are used. It is necessary to use sodium, sodium alginate, sodium polyacrylate, sodium carboxymethyl cellulose, various vegetable gums, soybean whey, etc. to give it a viscosity that does not easily disintegrate in water. [Action] Inventor's research It was discovered that glycyrrhizin also has effects on fish such as improving liver function, detoxification, and strengthening immunity.Therefore, if it is used in fish farming,
It is not adversely affected by poor quality feed with a high POV, and exhibits good rearing results, being less susceptible to diseases even in high-density aquaculture. Moreover, glycyrrhizin is a natural product and unlike antibiotics, it does not disrupt the natural microbial balance or accumulate in fish bodies, so it can be suitably used as a safe feed additive. [Examples] Hereinafter, embodiments of the invention will be explained using examples, but the examples are merely for explanation and do not mean any restriction or limitation on the idea of the invention. 1 kg of raw sardines, 50 g of pregelatinized starch, 2 glycyrrhizin
0 mg and vitamin E (antioxidant > 10 mg) were mixed with minced meat, the sown material was extruded into a radon shape, and was lightly dried with hot air to obtain about 1 kg of raw feed for young yellowtail fish. [Effects of the Invention] As explained above and demonstrated. As described above, the present invention provides a means for solving the above problems by developing a non-antibiotic drug for enhancing the biological defense function of fish and a feed containing the drug. (Margins below)

【図面の簡単な説明】[Brief explanation of drawings]

第1図は、グリチルリチンの投与によるブリ稚魚の体重
増加を示すグラフ、第2図は、グリチルリチンの投与に
よるヘマトクリット値及び血清蛋白量の変化を示すグラ
フ、第3図は、グリチルリチンの投与が血清中のGOT
及びGPTの値に及ぼす影響を示すグラフ、第4図は、
グリチルリチンの投与と、補体価、リゾチーム活性、貧
食率及び凝集抗体価の変化との相関を示すグラフ、第5
図は、投与開始から4週間後に、連鎖球菌S−2433
株のLDia量を接種したときのグリチルリチン投与量
と生存率との関係を示すグラフである。各グラフの縦横
パラメータその他の説明は、各図中に記載済み。 購 図 グリチルリチン添加量 (岨/体重1にg・日) グリチルリチン添加量 (mg/体重IKge日) グリチルリチン添加量 (脂g/体重IKg・日) グリチルリチン添加量 (IIg/体重IKg・日) グリチルリチン添加量 (mg/体重IKg・日)
Figure 1 is a graph showing the weight gain of yellowtail fry due to the administration of glycyrrhizin. Figure 2 is a graph showing the change in hematocrit value and serum protein level due to the administration of glycyrrhizin. Figure 3 is a graph showing the increase in body weight of yellowtail fry due to the administration of glycyrrhizin. GOT
A graph showing the influence on the value of GPT and GPT, FIG.
Graph showing the correlation between administration of glycyrrhizin and changes in complement value, lysozyme activity, hypophagia rate, and agglutinating antibody titer, 5th
The figure shows Streptococcus S-2433 after 4 weeks from the start of administration.
It is a graph showing the relationship between glycyrrhizin dosage and survival rate when the LDia amount of the strain is inoculated. The vertical and horizontal parameters of each graph and other explanations are already written in each figure. Added amount of glycyrrhizin (g fat/1 kg body weight/day) Added amount of glycyrrhizin (mg/I kg body weight/day) Added amount of glycyrrhizin (g fat/I kg body weight/day) Added amount of glycyrrhizin (II g/I kg body weight/day) Added glycyrrhizin Amount (mg/body weight IKg/day)

Claims (1)

【特許請求の範囲】 1 グリチルリチンを有効成分とする魚類の免疫増強剤
。 2 グリチルリチンを有効成分として含む養魚用餌料。
[Claims] 1. An immune enhancer for fish containing glycyrrhizin as an active ingredient. 2. Fish feed containing glycyrrhizin as an active ingredient.
JP1073152A 1989-03-23 1989-03-23 Fish immunopotentiator and fish culture feed Expired - Lifetime JP2840851B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1073152A JP2840851B2 (en) 1989-03-23 1989-03-23 Fish immunopotentiator and fish culture feed

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1073152A JP2840851B2 (en) 1989-03-23 1989-03-23 Fish immunopotentiator and fish culture feed

Publications (2)

Publication Number Publication Date
JPH02250832A true JPH02250832A (en) 1990-10-08
JP2840851B2 JP2840851B2 (en) 1998-12-24

Family

ID=13509925

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1073152A Expired - Lifetime JP2840851B2 (en) 1989-03-23 1989-03-23 Fish immunopotentiator and fish culture feed

Country Status (1)

Country Link
JP (1) JP2840851B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997008960A1 (en) * 1995-09-05 1997-03-13 Tetra Werke Dr. Rer. Nat. Ulrich Baensch Gmbh Antistress agents for aquatic animals
US7816340B2 (en) 2001-11-30 2010-10-19 Fmc Biopolymer As Oral immunostimulation of fish from (1-4) linked β-D-mannuronic acid
CN103070929A (en) * 2013-02-01 2013-05-01 中国水产科学研究院黑龙江水产研究所 Immunopotentiator for oncorhynchus masou masou

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997008960A1 (en) * 1995-09-05 1997-03-13 Tetra Werke Dr. Rer. Nat. Ulrich Baensch Gmbh Antistress agents for aquatic animals
AU718898B2 (en) * 1995-09-05 2000-04-20 Tetra Werke Dr. Rer. Nat. Ulrich Baensch Gmbh Anti-stress agents for aquatic animals
US6306453B1 (en) 1995-09-05 2001-10-23 Warner-Lambert Company Anti-stress agents for aquatic animals
US7816340B2 (en) 2001-11-30 2010-10-19 Fmc Biopolymer As Oral immunostimulation of fish from (1-4) linked β-D-mannuronic acid
CN103070929A (en) * 2013-02-01 2013-05-01 中国水产科学研究院黑龙江水产研究所 Immunopotentiator for oncorhynchus masou masou

Also Published As

Publication number Publication date
JP2840851B2 (en) 1998-12-24

Similar Documents

Publication Publication Date Title
KR20100101742A (en) Functional feed additives of marine fisheries and feeds for marine fisheries using thereof
Ashida et al. Immunostimulatory effects of fermented vegetable product on the non-specific immunity of Japanese flounder Paralichthys olivaceus
Meyers et al. First report of viral erythrocytic necrosis in Alaska, USA, associated with epizootic mortality in Pacific herring, Clupea harengus pallasi (Valenciennes)
JP4052534B2 (en) Seafood products and feed
KR20030069506A (en) Anti-white spot syndrome virus igy
JPH02250832A (en) Immunological enhancing agent for fishes and feed for fish-farming
CN112891363B (en) New Zealand vitexin 2 and new Zealand vitexin 3 application
JP3534792B2 (en) Disease resistant feed
JP6862541B2 (en) Aquatic animal feed
JP3013871B2 (en) Method for activating immune activity of marine cultured fish
FR2472389A1 (en) ANTIBIOTIC COMPOSITIONS CONTAINING MACROLIDE AND AMINOHETEROSIDE
JP2824185B2 (en) Fish immunostimulants
JPH05176689A (en) Feed for culturing fish
JPH0244814B2 (en)
CN114711347B (en) Combined preparation for improving disease resistance of marine cultured fish, preparation method and application thereof
JP3103615B2 (en) Preventive and therapeutic agent for pathogen infection added to formulated feed for cultured aquatic animals
JP2002199848A (en) Formulated feed for aquatic invertebrate
JPH0748274A (en) Production of preventing and therapeutic feed for pathogenic microbism in farming fishery
CN109385406A (en) One plant of vibrio parahaemolyticus phage and its application in terms of enhancing aquatic livestock immunity
CN110721174B (en) Medicine for preventing and treating fish myxosporidiosis
JPH0967265A (en) Antiviral agent against pathogenic virus of fishes
Nakajima Epigenetic Activation of Animals, Fish, Crustaceans, Mollusks, and Plants by Administration of Dimethylsulfoniopropionate in Green Sea Algae
US6908627B2 (en) Conditioned media for inhibiting growth of tumor cells
JPH06217712A (en) Feed for crustacean
RU2236248C2 (en) Immunotropic preparation &#34;vitulin&#34;

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071023

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091023

Year of fee payment: 11

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091023

Year of fee payment: 11